Teysuno 유럽 연합 - 슬로베니아어 - EMA (European Medicines Agency)

teysuno

nordic group b.v. - tegafur, gimeracil, oteracil - Želodne neoplazme - antineoplastična sredstva - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

URUTAL 24 mg tablete 슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

urutal 24 mg tablete

belupo, d.o.o., ljubljana - betahistin - tableta - betahistin 15,63 mg / 1 tableta - betahistin

URUTAL 24 mg tablete 슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

urutal 24 mg tablete

belupo, d.o.o., ljubljana - betahistin - tableta - betahistin 15,63 mg / 1 tableta - betahistin

URUTAL 8 mg tablete 슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

urutal 8 mg tablete

belupo, d.o.o., ljubljana - betahistin - tableta - betahistin 5,2 mg / 1 tableta - betahistin

URUTAL 16 mg tablete 슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

urutal 16 mg tablete

belupo, d.o.o., ljubljana - betahistin - tableta - betahistin 10,4 mg / 1 tableta - betahistin